Interestingly, we revealed dramatically decreased CXCR3 expression in all CD8+ T cell maturation subsets from patients with acute COVID-19 vs. COVID-19 convalescents and healthy controls (Figure 6E–H, Supplementary Table S4). The gene discussed is CXCR3; the disease is COVID-19.